SJS Investment Consulting’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.42K Buy
132
+2
+2% +$90 ﹤0.01% 1506
2026
Q2
$3.64K Buy
130
+119
+1,082% +$3.35K ﹤0.01% 1517
2026
Q1
$314 Buy
+11
New +$375 ﹤0.01% 1882
2023
Q1
– Sell
-4
Closed -$178 – 1584
2022
Q4
$178 Buy
4
+2
+100% +$84 ﹤0.01% 1431
2022
Q3
$0 Buy
+2
New +$91 ﹤0.01% 1042

Other funds holding ATRC

SJS Investment Consulting's ATRC Position: Q3 2026 in Review

SJS Investment Consulting increased its AtriCure (ATRC) stake by 1.5% in Q3 2026, buying an estimated $90 and bringing the position to 132 shares worth $7.42K. The position accounts for ﹤0.01% of the portfolio, ranked #1506.

SJS Investment Consulting first reported a position in ATRC in Q3 2022 and has held it in 5 quarters since. 283 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • SJS Investment Consulting held 132 shares of AtriCure worth $7.42K as of Q3 2026.
  • SJS Investment Consulting bought 2 AtriCure shares in Q3 2026, an estimated $90.
  • AtriCure made up ﹤0.01% of SJS Investment Consulting's portfolio in Q3 2026, its #1506 holding.
  • SJS Investment Consulting first reported a position in AtriCure in Q3 2022 and has held it in 5 quarters since.
  • 283 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on SJS Investment Consulting's 13F filing for Q3 2026, filed 26 Oct 2026.